These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25866037)

  • 41. [The current potentials for optimal whole-blood transfusion and component therapy with blood products--erythrocytes in obstetrics and gynecology--the indications, means and methods].
    Nikolov A; Kovachev I; Gŭrcheva L; Dimitrov A
    Akush Ginekol (Sofiia); 1998; 37(4):46-9. PubMed ID: 10360055
    [No Abstract]   [Full Text] [Related]  

  • 42. All massive transfusion criteria are not created equal: defining the predictive value of individual transfusion triggers to better determine who benefits from blood.
    Callcut RA; Johannigman JA; Kadon KS; Hanseman DJ; Robinson BR
    J Trauma; 2011 Apr; 70(4):794-801. PubMed ID: 21610387
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The use of fresh whole blood transfusions by the SOF medic for hemostatic resuscitation in the austere environment.
    Redman T
    J Spec Oper Med; 2010; 10(4):56; author reply 57. PubMed ID: 21442594
    [No Abstract]   [Full Text] [Related]  

  • 44. Revalidation and update of the TASH-Score: a scoring system to predict the probability for massive transfusion as a surrogate for life-threatening haemorrhage after severe injury.
    Maegele M; Lefering R; Wafaisade A; Theodorou P; Wutzler S; Fischer P; Bouillon B; Paffrath T;
    Vox Sang; 2011 Feb; 100(2):231-8. PubMed ID: 20735809
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Predicting the need for massive transfusion in trauma patients: the Traumatic Bleeding Severity Score.
    Ogura T; Nakamura Y; Nakano M; Izawa Y; Nakamura M; Fujizuka K; Suzukawa M; Lefor AT
    J Trauma Acute Care Surg; 2014 May; 76(5):1243-50. PubMed ID: 24747455
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The use of fresh whole blood in massive transfusion.
    Repine TB; Perkins JG; Kauvar DS; Blackborne L
    J Trauma; 2006 Jun; 60(6 Suppl):S59-69. PubMed ID: 16763483
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Massive blood loss in trauma patients. The benefits and dangers of transfusion therapy.
    Phillips GR; Kauder DR; Schwab CW
    Postgrad Med; 1994 Mar; 95(4):61-2, 67-72. PubMed ID: 8121860
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Massive transfusion: an overview of the main characteristics and potential risks associated with substances used for correction of a coagulopathy.
    Seghatchian J; Samama MM
    Transfus Apher Sci; 2012 Oct; 47(2):235-43. PubMed ID: 22770808
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transfusion Approaches and Mortality in Trauma Patients: A Narrative Review.
    Fries D; Innerhofer P; Spahn DR
    Semin Thromb Hemost; 2017 Oct; 43(7):759-771. PubMed ID: 28895646
    [No Abstract]   [Full Text] [Related]  

  • 50. Frequency and characteristics of coagulopathy in trauma patients treated with a low- or high-plasma-content massive transfusion protocol.
    Chambers LA; Chow SJ; Shaffer LE
    Am J Clin Pathol; 2011 Sep; 136(3):364-70. PubMed ID: 21846911
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Blood and coagulation support in trauma.
    Murthi SB; Stansbury LG; Hess JR
    Blood Rev; 2009 Jul; 23(4):149-55. PubMed ID: 19138811
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Design and preliminary results of a pilot randomized controlled trial on a 1:1:1 transfusion strategy: the trauma formula-driven versus laboratory-guided study.
    Nascimento B; Rizoli S; Rubenfeld G; Lin Y; Callum J; Tien HC
    J Trauma; 2011 Nov; 71(5 Suppl 1):S418-26. PubMed ID: 22071998
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transfusion strategies for traumatic coagulopathy.
    Curry NS; Davenport RA; Hunt BJ; Stanworth SJ
    Blood Rev; 2012 Sep; 26(5):223-32. PubMed ID: 22795890
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The PRospective Observational Multicenter Major Trauma Transfusion (PROMMTT) study.
    Holcomb JB; Fox EE; Wade CE;
    J Trauma Acute Care Surg; 2013 Jul; 75(1 Suppl 1):S1-2. PubMed ID: 23778505
    [No Abstract]   [Full Text] [Related]  

  • 55. Massive transfusion: assessing higher plasma: blood ratios and earlier plasma administration.
    Godier A; Ozier Y; Susen S;
    Eur J Anaesthesiol; 2011 Mar; 28(3):149-51. PubMed ID: 21325899
    [No Abstract]   [Full Text] [Related]  

  • 56. Is an age-of-blood transfusion trial in trauma patients in Australia and New Zealand feasible?
    Aubron C; Kaukonen KM; McQuilten Z; Cameron P; Bailey M; Cooper DJ
    Crit Care Resusc; 2013 Sep; 15(3):159-61. PubMed ID: 23944200
    [No Abstract]   [Full Text] [Related]  

  • 57. Thromboelastography-guided transfusion Therapy in the trauma patient.
    Brazzel C
    AANA J; 2013 Apr; 81(2):127-32. PubMed ID: 23971232
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The coagulopathy of massive transfusion.
    Hardy JF; de Moerloose P; Samama CM
    Vox Sang; 2005 Oct; 89(3):123-7. PubMed ID: 16146503
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Methodological approaches toward higher safety of hemotransfusion therapy].
    Moskalenko VF; Orlyk VV; Gorban' IeM; Novak VL
    Lik Sprava; 2000 Sep; (6):3-8. PubMed ID: 11452914
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Blood transfusion: a practical guide.
    Burdett E; Stephens R
    Br J Hosp Med (Lond); 2006 Apr; 67(4):M67-9. PubMed ID: 16681309
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.